Digital Self-Management for Inflammatory Bowel Disease

SC
Overseen ByShirley Cohen-Mekelburg, MD, MS
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Michigan
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This research is studying whether changing an individual's behaviors may have an impact as a treatment or outcome for inflammatory bowel disease. This research will increase the understanding of the role of a self-management program in improving health and health-related quality of life for patients with inflammatory bowel disease.

The study team hypothesizes:

* the study will achieve a recruitment rate of 10 participants every 3 months

* 70% participant retention at 24 weeks

* 70% outcome data collection

* 70% intervention completion

* high acceptability

Who Is on the Research Team?

SC

Shirley Cohen-Mekelburg, MD, MS

Principal Investigator

University of Michigan

Are You a Good Fit for This Trial?

Inclusion Criteria

I have been diagnosed with active inflammatory bowel disease.
* Impaired health-related quality of life
My Crohn's or ulcerative colitis is currently active.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in a 24-week digital self-management program to improve health outcomes for inflammatory bowel disease

24 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Digital self-management program

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Standard Care plus digital self-management programExperimental Treatment2 Interventions
Group II: Standard careActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Michigan

Lead Sponsor

Trials
1,891
Recruited
6,458,000+

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Trials
2,513
Recruited
4,366,000+